Literature DB >> 26186886

Does low well-being modify the effects of PRISMA (Dutch DESMOND), a structured self-management-education program for people with type 2 diabetes?

Michael van Vugt1, Maartje de Wit2, Suzanne Bader3, Frank J Snoek2.   

Abstract

AIMS: Diabetes self-management education improves behavioural and clinical outcomes in type 2 diabetes patients, however little is known about the modifying effects of well-being. This is relevant given high prevalence of depression and distress among diabetes patients. We aimed to test whether low well-being modifies the effects of the PRISMA self-management education program (Dutch DESMOND).
METHODS: 297 primary care type 2 diabetes patients participated in the PRISMA observational study with a pre-post measurement design. Patients were grouped in low (n=63) and normal well-being (n=234). Low well-being was defined as either low mood (WHO-5<50) and/or high diabetes-distress (PAID-5>8). Outcome measures were: diabetes self-efficacy (CIDS), illness perception (IPQ) and diabetes self-care activities (SDSCA).
RESULTS: Improvements were found in illness perception (b=1.586, p<0.001), general diet (b=1.508, p=0.001), foot care (b=0.678, p=0.037), weekly average diet (b=1.140, p=0.001), creating action plan (b=0.405, p=0.007). Well-being interaction effects were found for general diet (p=0.009), weekly average diet (p=0.022), and creating an action plan (p=0.002).
CONCLUSIONS: PRISMA self-management education seems as effective for people with normal well-being as for people with low well-being. Further research should examine whether addressing mood and diabetes-distress as part of self-management education could reduce attrition and maintain or improve well-being among participants.
Copyright © 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Education; Self-management; Type 2 diabetes mellitus; Well-being

Mesh:

Year:  2015        PMID: 26186886     DOI: 10.1016/j.pcd.2015.06.008

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  6 in total

1.  Effects of a Proactive Interdisciplinary Self-Management (PRISMA) program on medication adherence in patients with type 2 diabetes in primary care: a randomized controlled trial.

Authors:  Esther du Pon; Siham El Azzati; Ad van Dooren; Nanne Kleefstra; Eibert Heerdink; Sandra van Dulmen
Journal:  Patient Prefer Adherence       Date:  2019-05-10       Impact factor: 2.711

2.  Distress and Type 2 Diabetes Self-Care: Putting the Pieces Together.

Authors:  Claire J Hoogendoorn; Clyde B Schechter; Maria M Llabre; Elizabeth A Walker; Jeffrey S Gonzalez
Journal:  Ann Behav Med       Date:  2021-10-04

3.  Effects of a Proactive Interdisciplinary Self-Management Program on Patient Self-Efficacy and Participation During Practice Nurse Consultations: A Randomized Controlled Trial in Type 2 Diabetes.

Authors:  Esther du Pon; Ad van Dooren; Nanne Kleefstra; Sandra van Dulmen
Journal:  J Clin Med Res       Date:  2020-02-01

4.  Effects of the Proactive interdisciplinary self-management (PRISMA) program on self-reported and clinical outcomes in type 2 diabetes: a pragmatic randomized controlled trial.

Authors:  Esther du Pon; Nanne Kleefstra; Frits Cleveringa; Ad van Dooren; Eibert R Heerdink; Sandra van Dulmen
Journal:  BMC Endocr Disord       Date:  2019-12-11       Impact factor: 2.763

5.  Effects of the Proactive Interdisciplinary Self-Management (PRISMA) Program on Online Care Platform Usage in Patients with Type 2 Diabetes in Primary Care: A Randomized Controlled Trial.

Authors:  Esther du Pon; Nanne Kleefstra; Frits Cleveringa; Ad van Dooren; Eibert R Heerdink; Sandra van Dulmen
Journal:  J Diabetes Res       Date:  2020-01-08       Impact factor: 4.011

6.  Diabetes-related quality of life in six European countries measured with the DOQ-30.

Authors:  Liina Pilv; Etienne I J J Vermeire; Anneli Rätsep; Alain Moreau; Davorina Petek; Hakan Yaman; Marje Oona; Ruth Kalda
Journal:  Eur J Gen Pract       Date:  2021-12       Impact factor: 1.904

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.